DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

194.90 0.18 (0.09%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ALXN $194.90 0.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $195.47
Previous Close $194.72
Daily Range $193.52 - $196.49
52-Week Range $120.14 - $197.64
Market Cap $38.6B
P/E Ratio 81.13
Dividend (Yield) $0.00 (0.0%)
Volume 576,622
Average Daily Volume 1,055,534
Current FY EPS $4.72





Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website:

News & Commentary

Is This Trend Making Gilead Sciences, Inc. Worry?

In a bid to control costs, healthcare payers are restricting who can be prescribed Gilead Sciences' Harvoni.

Alexion's Soliris Gets Final Positive NICE Recommendation - Analyst Blog

Health Care Sector Update for 11/28/2014: ALXN, NVS, DVAX

Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog

Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog

Mixed Readings For Biotech Short Interest

Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer

US Stock Futures Edge Higher Ahead Of GDP, Housing Data

Stock Market News for November 19, 2014 - Market News

Why Celldex Therapeutics' Stock Is Now Ready For Takeoff

Gilead Has Been Rocked After Earnings, But I'm Looking To Buy!

Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining

See More ALXN News...

ALXN's Top Competitors

ALXN $194.90 (0.09%)
Current stock: ALXN
AMGN $165.31 (0.36%)
Current stock: AMGN
GILD $100.20 (-0.10%)
Current stock: GILD
BIIB $307.62 (0.89%)
Current stock: BIIB